 | • レポートコード：MRC2-11QY04952 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、99ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は尿路感染症治療のグローバル市場について調査・分析したレポートです。種類別（複雑なUTI、再発性の複雑なUTI、単純なUTI、神経因性膀胱感染症、その他）市場規模、用途別（病院薬局、婦人科および泌尿器科クリニック、ドラッグストア、小売薬局、オンラインドラッグストア）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別尿路感染症治療の競争状況、市場シェア ・世界の尿路感染症治療市場：種類別市場規模 2015年-2020年（複雑なUTI、再発性の複雑なUTI、単純なUTI、神経因性膀胱感染症、その他） ・世界の尿路感染症治療市場：種類別市場規模予測 2021年-2026年（複雑なUTI、再発性の複雑なUTI、単純なUTI、神経因性膀胱感染症、その他） ・世界の尿路感染症治療市場：用途別市場規模 2015年-2020年（病院薬局、婦人科および泌尿器科クリニック、ドラッグストア、小売薬局、オンラインドラッグストア） ・世界の尿路感染症治療市場：用途別市場規模予測 2021年-2026年（病院薬局、婦人科および泌尿器科クリニック、ドラッグストア、小売薬局、オンラインドラッグストア） ・北米の尿路感染症治療市場分析：米国、カナダ ・ヨーロッパの尿路感染症治療市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの尿路感染症治療市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の尿路感染症治療市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの尿路感染症治療市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Johnson & Johnson、Novartis、Pfizer、Merck ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Urinary tract infection (UTI) is a common infections of the urinary tract, which consists of the kidneys, ureters, bladder, urethra or prostate gland.
This trend of increment in the prevalence rate of diabetes among adults is expected to continue during the forecast period. Therefore, with increasing prevalence, the number of UTI increases, and thus, the high demand for drugs. Hence, increasing prevalence of diabetes worldwide is expected to act as a major driver for the global urinary tract infection therapeutics market.
Market Analysis and Insights: Global Urinary Tract Infection Treatment Market
The global Urinary Tract Infection Treatment market size is projected to reach US$ 72660 million by 2026, from US$ 71130 million in 2020, at a CAGR of 2.0%% during 2021-2026.
Global Urinary Tract Infection Treatment Scope and Market Size
Urinary Tract Infection Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Urinary Tract Infection Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Johnson & Johnson
Novartis
Pfizer
Merck
…
Market segment by Type, the product can be split into
Complicated UTI
Recurring Complicated UTI
Uncomplicated UTI
Neurogenic Bladder Infections
Others
Market segment by Application, split into
Hospital Pharmacies
Gynaecology and Urology Clinics
Drug Store
Retail Pharmacies
Online Drug Stores
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Urinary Tract Infection Treatment Revenue
1.4 Market by Type
1.4.1 Global Urinary Tract Infection Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Complicated UTI
1.4.3 Recurring Complicated UTI
1.4.4 Uncomplicated UTI
1.4.5 Neurogenic Bladder Infections
1.4.6 Others
1.5 Market by Application
1.5.1 Global Urinary Tract Infection Treatment Market Share by Application: 2020 VS 2026
1.5.2 Hospital Pharmacies
1.5.3 Gynaecology and Urology Clinics
1.5.4 Drug Store
1.5.5 Retail Pharmacies
1.5.6 Online Drug Stores
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Urinary Tract Infection Treatment Market Perspective (2015-2026)
2.2 Global Urinary Tract Infection Treatment Growth Trends by Regions
2.2.1 Urinary Tract Infection Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Urinary Tract Infection Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Urinary Tract Infection Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Urinary Tract Infection Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Urinary Tract Infection Treatment Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Urinary Tract Infection Treatment Players by Market Size
3.1.1 Global Top Urinary Tract Infection Treatment Players by Revenue (2015-2020)
3.1.2 Global Urinary Tract Infection Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Urinary Tract Infection Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Urinary Tract Infection Treatment Market Concentration Ratio
3.2.1 Global Urinary Tract Infection Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Urinary Tract Infection Treatment Revenue in 2019
3.3 Urinary Tract Infection Treatment Key Players Head office and Area Served
3.4 Key Players Urinary Tract Infection Treatment Product Solution and Service
3.5 Date of Enter into Urinary Tract Infection Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Urinary Tract Infection Treatment Historic Market Size by Type (2015-2020)
4.2 Global Urinary Tract Infection Treatment Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Urinary Tract Infection Treatment Market Size by Application (2015-2020)
5.2 Global Urinary Tract Infection Treatment Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Urinary Tract Infection Treatment Market Size (2015-2020)
6.2 Urinary Tract Infection Treatment Key Players in North America (2019-2020)
6.3 North America Urinary Tract Infection Treatment Market Size by Type (2015-2020)
6.4 North America Urinary Tract Infection Treatment Market Size by Application (2015-2020)
7 Europe
7.1 Europe Urinary Tract Infection Treatment Market Size (2015-2020)
7.2 Urinary Tract Infection Treatment Key Players in Europe (2019-2020)
7.3 Europe Urinary Tract Infection Treatment Market Size by Type (2015-2020)
7.4 Europe Urinary Tract Infection Treatment Market Size by Application (2015-2020)
8 China
8.1 China Urinary Tract Infection Treatment Market Size (2015-2020)
8.2 Urinary Tract Infection Treatment Key Players in China (2019-2020)
8.3 China Urinary Tract Infection Treatment Market Size by Type (2015-2020)
8.4 China Urinary Tract Infection Treatment Market Size by Application (2015-2020)
9 Japan
9.1 Japan Urinary Tract Infection Treatment Market Size (2015-2020)
9.2 Urinary Tract Infection Treatment Key Players in Japan (2019-2020)
9.3 Japan Urinary Tract Infection Treatment Market Size by Type (2015-2020)
9.4 Japan Urinary Tract Infection Treatment Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Urinary Tract Infection Treatment Market Size (2015-2020)
10.2 Urinary Tract Infection Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Urinary Tract Infection Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Urinary Tract Infection Treatment Market Size by Application (2015-2020)
11 India
11.1 India Urinary Tract Infection Treatment Market Size (2015-2020)
11.2 Urinary Tract Infection Treatment Key Players in India (2019-2020)
11.3 India Urinary Tract Infection Treatment Market Size by Type (2015-2020)
11.4 India Urinary Tract Infection Treatment Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Urinary Tract Infection Treatment Market Size (2015-2020)
12.2 Urinary Tract Infection Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Urinary Tract Infection Treatment Market Size by Type (2015-2020)
12.4 Central & South America Urinary Tract Infection Treatment Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Johnson & Johnson
13.1.1 Johnson & Johnson Company Details
13.1.2 Johnson & Johnson Business Overview
13.1.3 Johnson & Johnson Urinary Tract Infection Treatment Introduction
13.1.4 Johnson & Johnson Revenue in Urinary Tract Infection Treatment Business (2015-2020))
13.1.5 Johnson & Johnson Recent Development
13.2 Novartis
13.2.1 Novartis Company Details
13.2.2 Novartis Business Overview
13.2.3 Novartis Urinary Tract Infection Treatment Introduction
13.2.4 Novartis Revenue in Urinary Tract Infection Treatment Business (2015-2020)
13.2.5 Novartis Recent Development
13.3 Pfizer
13.3.1 Pfizer Company Details
13.3.2 Pfizer Business Overview
13.3.3 Pfizer Urinary Tract Infection Treatment Introduction
13.3.4 Pfizer Revenue in Urinary Tract Infection Treatment Business (2015-2020)
13.3.5 Pfizer Recent Development
13.4 Merck
13.4.1 Merck Company Details
13.4.2 Merck Business Overview
13.4.3 Merck Urinary Tract Infection Treatment Introduction
13.4.4 Merck Revenue in Urinary Tract Infection Treatment Business (2015-2020)
13.4.5 Merck Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Urinary Tract Infection Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Urinary Tract Infection Treatment Revenue
Table 3. Ranking of Global Top Urinary Tract Infection Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Urinary Tract Infection Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Complicated UTI
Table 6. Key Players of Recurring Complicated UTI
Table 7. Key Players of Uncomplicated UTI
Table 8. Key Players of Neurogenic Bladder Infections
Table 9. Key Players of Others
Table 10. Global Urinary Tract Infection Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 11. Global Urinary Tract Infection Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 12. Global Urinary Tract Infection Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 13. Global Urinary Tract Infection Treatment Market Share by Regions (2015-2020)
Table 14. Global Urinary Tract Infection Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 15. Global Urinary Tract Infection Treatment Market Share by Regions (2021-2026)
Table 16. Market Top Trends
Table 17. Key Drivers: Impact Analysis
Table 18. Key Challenges
Table 19. Urinary Tract Infection Treatment Market Growth Strategy
Table 20. Main Points Interviewed from Key Urinary Tract Infection Treatment Players
Table 21. Global Urinary Tract Infection Treatment Revenue by Players (2015-2020) (Million US$)
Table 22. Global Urinary Tract Infection Treatment Market Share by Players (2015-2020)
Table 23. Global Top Urinary Tract Infection Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Urinary Tract Infection Treatment as of 2019)
Table 24. Global Urinary Tract Infection Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Urinary Tract Infection Treatment Product Solution and Service
Table 27. Date of Enter into Urinary Tract Infection Treatment Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Urinary Tract Infection Treatment Market Size by Type (2015-2020) (Million US$)
Table 30. Global Urinary Tract Infection Treatment Market Size Share by Type (2015-2020)
Table 31. Global Urinary Tract Infection Treatment Revenue Market Share by Type (2021-2026)
Table 32. Global Urinary Tract Infection Treatment Market Size Share by Application (2015-2020)
Table 33. Global Urinary Tract Infection Treatment Market Size by Application (2015-2020) (Million US$)
Table 34. Global Urinary Tract Infection Treatment Market Size Share by Application (2021-2026)
Table 35. North America Key Players Urinary Tract Infection Treatment Revenue (2019-2020) (Million US$)
Table 36. North America Key Players Urinary Tract Infection Treatment Market Share (2019-2020)
Table 37. North America Urinary Tract Infection Treatment Market Size by Type (2015-2020) (Million US$)
Table 38. North America Urinary Tract Infection Treatment Market Share by Type (2015-2020)
Table 39. North America Urinary Tract Infection Treatment Market Size by Application (2015-2020) (Million US$)
Table 40. North America Urinary Tract Infection Treatment Market Share by Application (2015-2020)
Table 41. Europe Key Players Urinary Tract Infection Treatment Revenue (2019-2020) (Million US$)
Table 42. Europe Key Players Urinary Tract Infection Treatment Market Share (2019-2020)
Table 43. Europe Urinary Tract Infection Treatment Market Size by Type (2015-2020) (Million US$)
Table 44. Europe Urinary Tract Infection Treatment Market Share by Type (2015-2020)
Table 45. Europe Urinary Tract Infection Treatment Market Size by Application (2015-2020) (Million US$)
Table 46. Europe Urinary Tract Infection Treatment Market Share by Application (2015-2020)
Table 47. China Key Players Urinary Tract Infection Treatment Revenue (2019-2020) (Million US$)
Table 48. China Key Players Urinary Tract Infection Treatment Market Share (2019-2020)
Table 49. China Urinary Tract Infection Treatment Market Size by Type (2015-2020) (Million US$)
Table 50. China Urinary Tract Infection Treatment Market Share by Type (2015-2020)
Table 51. China Urinary Tract Infection Treatment Market Size by Application (2015-2020) (Million US$)
Table 52. China Urinary Tract Infection Treatment Market Share by Application (2015-2020)
Table 53. Japan Key Players Urinary Tract Infection Treatment Revenue (2019-2020) (Million US$)
Table 54. Japan Key Players Urinary Tract Infection Treatment Market Share (2019-2020)
Table 55. Japan Urinary Tract Infection Treatment Market Size by Type (2015-2020) (Million US$)
Table 56. Japan Urinary Tract Infection Treatment Market Share by Type (2015-2020)
Table 57. Japan Urinary Tract Infection Treatment Market Size by Application (2015-2020) (Million US$)
Table 58. Japan Urinary Tract Infection Treatment Market Share by Application (2015-2020)
Table 59. Southeast Asia Key Players Urinary Tract Infection Treatment Revenue (2019-2020) (Million US$)
Table 60. Southeast Asia Key Players Urinary Tract Infection Treatment Market Share (2019-2020)
Table 61. Southeast Asia Urinary Tract Infection Treatment Market Size by Type (2015-2020) (Million US$)
Table 62. Southeast Asia Urinary Tract Infection Treatment Market Share by Type (2015-2020)
Table 63. Southeast Asia Urinary Tract Infection Treatment Market Size by Application (2015-2020) (Million US$)
Table 64. Southeast Asia Urinary Tract Infection Treatment Market Share by Application (2015-2020)
Table 65. India Key Players Urinary Tract Infection Treatment Revenue (2019-2020) (Million US$)
Table 66. India Key Players Urinary Tract Infection Treatment Market Share (2019-2020)
Table 67. India Urinary Tract Infection Treatment Market Size by Type (2015-2020) (Million US$)
Table 68. India Urinary Tract Infection Treatment Market Share by Type (2015-2020)
Table 69. India Urinary Tract Infection Treatment Market Size by Application (2015-2020) (Million US$)
Table 70. India Urinary Tract Infection Treatment Market Share by Application (2015-2020)
Table 71. Central & South America Key Players Urinary Tract Infection Treatment Revenue (2019-2020) (Million US$)
Table 72. Central & South America Key Players Urinary Tract Infection Treatment Market Share (2019-2020)
Table 73. Central & South America Urinary Tract Infection Treatment Market Size by Type (2015-2020) (Million US$)
Table 74. Central & South America Urinary Tract Infection Treatment Market Share by Type (2015-2020)
Table 75. Central & South America Urinary Tract Infection Treatment Market Size by Application (2015-2020) (Million US$)
Table 76. Central & South America Urinary Tract Infection Treatment Market Share by Application (2015-2020)
Table 77. Johnson & Johnson Company Details
Table 78. Johnson & Johnson Business Overview
Table 79. Johnson & Johnson Product
Table 80. Johnson & Johnson Revenue in Urinary Tract Infection Treatment Business (2015-2020) (Million US$)
Table 81. Johnson & Johnson Recent Development
Table 82. Novartis Company Details
Table 83. Novartis Business Overview
Table 84. Novartis Product
Table 85. Novartis Revenue in Urinary Tract Infection Treatment Business (2015-2020) (Million US$)
Table 86. Novartis Recent Development
Table 87. Pfizer Company Details
Table 88. Pfizer Business Overview
Table 89. Pfizer Product
Table 90. Pfizer Revenue in Urinary Tract Infection Treatment Business (2015-2020) (Million US$)
Table 91. Pfizer Recent Development
Table 92. Merck Company Details
Table 93. Merck Business Overview
Table 94. Merck Product
Table 95. Merck Revenue in Urinary Tract Infection Treatment Business (2015-2020) (Million US$)
Table 96. Merck Recent Development
Table 97. Research Programs/Design for This Report
Table 98. Key Data Information from Secondary Sources
Table 99. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Urinary Tract Infection Treatment Market Share by Type: 2020 VS 2026
Figure 2. Complicated UTI Features
Figure 3. Recurring Complicated UTI Features
Figure 4. Uncomplicated UTI Features
Figure 5. Neurogenic Bladder Infections Features
Figure 6. Others Features
Figure 7. Global Urinary Tract Infection Treatment Market Share by Application: 2020 VS 2026
Figure 8. Hospital Pharmacies Case Studies
Figure 9. Gynaecology and Urology Clinics Case Studies
Figure 10. Drug Store Case Studies
Figure 11. Retail Pharmacies Case Studies
Figure 12. Online Drug Stores Case Studies
Figure 13. Urinary Tract Infection Treatment Report Years Considered
Figure 14. Global Urinary Tract Infection Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 15. Global Urinary Tract Infection Treatment Market Share by Regions: 2020 VS 2026
Figure 16. Global Urinary Tract Infection Treatment Market Share by Regions (2021-2026)
Figure 17. Porter's Five Forces Analysis
Figure 18. Global Urinary Tract Infection Treatment Market Share by Players in 2019
Figure 19. Global Top Urinary Tract Infection Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Urinary Tract Infection Treatment as of 2019
Figure 20. The Top 10 and 5 Players Market Share by Urinary Tract Infection Treatment Revenue in 2019
Figure 21. North America Urinary Tract Infection Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Europe Urinary Tract Infection Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. China Urinary Tract Infection Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Japan Urinary Tract Infection Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Southeast Asia Urinary Tract Infection Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. India Urinary Tract Infection Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Central & South America Urinary Tract Infection Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 28. Bottom-up and Top-down Approaches for This Report
Figure 29. Data Triangulation
Figure 30. Key Executives Interviewed
下気道感染症治療の世界市場（～2026年） The infection below the level of larynx is said to be lower respiratory tract infection. Many a times, lower respiratory tract infection is called pneumonia. These infection are not defined uniformly, but epidemiologically, these infections includes flu, bronchitis, bronchiolitis, and pneumonia. The…- 気道感染症治療の世界市場（～2026年） Market Analysis and Insights: Global Respiratory Tract Infection Treatment Market The global Respiratory Tract Infection Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Respiratory Tract Infection Treatment S…
- 医療関連感染（HAI）治療の世界市場（～2026年） Hospital Acquired Infection Treatment is an infection that is acquired in a hospital or other health care facility. Market Analysis and Insights: Global Hospital Acquired Infection Treatment Market The global Hospital Acquired Infection Treatment market size is projected to reach US$ 19430 million b…
- 医療関連感染（HAI）管理の世界市場（～2026年） A hospital-acquired infection (HAI), also known as a nosocomial infection, is an infection that is acquired in a hospital or other health care facility. The rise in the incidences of different types of hospital acquired infections, innovative technologies implemented in devices that control infectio…
- 院内感染治療の世界市場（～2026年） Hospital-acquired infections, also known as nosocomial infections, are acquired by patients in the hospitals or healthcare facilities. Urinary tract infections, bloodstream infections, surgical-site infections, Clostridium difficile associated diarrhea, and pneumonia are examples of nosocomial infec…